Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Finance and insurance tags : Disease save search
Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
SILO | $1.97 0.0% 40K
|
Finance and Insurance
|
| O: 1.87%
H: 4.59%
C: -3.67%
pharma disease alzheimer’s acquire spc-14
Silo Pharma Announces Positive Results in Alzheimer’s Disease Study
Published: 2024-01-24 (Crawled : 14:00) - globenewswire.com
SILO | $1.97 0.0% 40K
|
Finance and Insurance
|
| O: 10.0%
H: 5.19%
C: -3.9%
pharma disease alzheimer’s positive results study
Silo Pharma’s SPU-21 Treatment for Autoimmune Disease Awarded U.S. Patent
Published: 2023-06-21 (Crawled : 13:00) - globenewswire.com
SILO | $1.97 0.0% 40K
|
Finance and Insurance
|
| O: 5.74%
H: 0.0%
C: -4.98%
spu-21 patent disease treatment
PTC, chasing BioMarin, posts phase 3 rare disease win but fails to … – FierceBiotech
Published: 2023-05-18 (Crawled : 14:20) - spacfeed.com
SOFI 4 | $7.12 -0.14% -0.14% 36M
|
Finance and Insurance
|
| O: 0.4%
H: 3.11%
C: 1.81%
rare disease
Silo Pharma’s SPC-15 Awarded U.S. Patent Protecting Ongoing R&D of Therapeutic for Stress-Induced Affective Disorder and Alzheimer’s Disease
Published: 2023-05-09 (Crawled : 12:00) - globenewswire.com
SILO | $1.97 0.0% 40K
|
Finance and Insurance
|
| O: -3.6%
H: 5.14%
C: 0.47%
spc-15 patent disease alzheimer’s ongoing spc-14
Silo Pharma Announces Data Supporting Therapeutic Potential of SPC-14 for Alzheimer’s Disease in Pre-Clinical Study
Published: 2022-10-20 (Crawled : 12:20) - globenewswire.com
SILO | $1.97 0.0% 40K
|
Finance and Insurance
|
| O: 2.72%
H: 1.22%
C: -15.27%
spc-14 pharma disease pre-clinical alzheimer’s potential study
Silo Pharma Announces Successful Dosing of Patients Suffering from Parkinson’s Disease in Psilocybin Study
Published: 2022-05-19 (Crawled : 12:20) - globenewswire.com
SILO | $1.97 0.0% 40K
|
Finance and Insurance
|
| O: 0.2%
H: 0.0%
C: -2.62%
pharma disease psilocybin
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.